<DOC>
	<DOCNO>NCT00441519</DOCNO>
	<brief_summary>To compare gastroprotective effect once-daily dose PA 325 combination tablet</brief_summary>
	<brief_title>A Parallel Group Study Compare Gastroprotective Effects PA 325 Versus 81 mg Enteric Coated Aspirin</brief_title>
	<detailed_description>Primary : To compare gastroprotective effect once-daily dose PA 325 combination tablet combine 325 mg pH sensitive aspirin 20 mg immediate release omeprazole versus once-daily dose 81 mg enteric coat ( EC ) aspirin utilize Lanza score endoscopy finding normal healthy volunteer . Secondary : To evaluate safety gastrointestinal tolerability , include ulcerogenic potential , effect gastric pH PA 325 .</detailed_description>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<criteria>1 . Subject male female pregnant lactating . A female eligible enter participate study : Nonchildbearing potential ( i.e. , physiologically incapable become pregnant ) ; , Childbearing potential negative pregnancy test screening , least one follow applies agree subject : Complete abstinence intercourse least 14 day prior first dose study medication , throughout study 30 day completion study Female sterilization sterilization male partner ; , Hormonal contraception oral route , implant , injectable , vaginal ring ; , Any intrauterine device ( IUD ) publish data show low expected failure rate le 1 % per year ; Double barrier method ( 2 physical barrier 1 physical barrier plus spermicide ) ; Any method publish data show low expected failure rate le 1 % per year 2 . Subject &gt; 50 year age inclusive time dose 3 . Subject currently smoke smoke least 3 month 4 . The subject 's physical status within normal limit age consistent observation screen 5 . The subject 's Body Mass Index ( BMI ) 2030 kg/m2 6 . Each subject must able understand comply study procedure require subject able willing provide write informed consent prior study procedure perform 1 . History hypersensitivity omeprazole another protonpump inhibitor 2 . History allergic reaction intolerance aspirin NSAID and/or history NSAIDinduced symptom asthma , rhinitis , and/or nasal polyp 3 . Participation study investigational treatment 4 week Day 1 dose 4 . Presence uncontrolled acute chronic medical illness , e.g . GI disorder , hypertension , diabetes , thyroid disorder , depression and/or infection would endanger subject participate study 5 . GI disorder surgery lead impaired drug absorption 6 . Evidence uncontrolled , unstable cardio cerebrovascular disorder , investigator 's opinion , would endanger subject participate study 7 . Schizophrenia bipolar disorder 8 . Use concomitant medication approve study physician washout period study conduct 9 . Serious blood coagulation disorder , include use systemic anticoagulant 10 . Subjects donate 50 499 mL blood within 30 day 499 mL within 56 day prior dose 11 . Subjects , completion study , would donate excess : 500 mL blood 14 day ; 1,500 mL blood 180 day ; 2,500 mL blood 1 year 12 . Baseline endoscopy show gastric duodenal mucosal abnormality ( hemorrhage , ulcer erosion ) 13 . Gastric pH &gt; 3 Day 1 endoscopy 14 . Screening laboratory alanine transaminase ( ALT ) aspartate transaminase ( AST ) value &gt; 2 time upper limit normal 15 . Estimated creatinine clearance &lt; 30 ml/min screen 16 . Other note specifically , screen laboratory value clinically significant investigator 's opinion would endanger subject participate study 17 . History hepatitis B C , positive test hepatitis B surface antigen , hepatitis C antibody , history HIV infection , demonstration HIV antibodies 18 . History malignancy , treat untreated , within past 5 year , exception successfully treat basal cell squamous cell carcinoma skin 19 . Subjects previously screen failure study 20 . Subject excessive alcohol use ( &gt; 2 unit per day average ; example 2 bottle beer , two glass wine , 2 ounce liquor/spirits ) , recent history ( past 3 month ) suggestive alcohol drug abuse dependence 21 . Subject ingested grapefruit grapefruit juice within 10 day dose ingest grapefruit grapefruit juice duration study 22 . Positive illicit drug screen</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>Gastroprotective effect</keyword>
	<keyword>Aspirin</keyword>
</DOC>